PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCJ40
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $47,661
Award facts
- Contract value 100% obligated
- $47,660.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,660.69 by the Department of Defense Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract represents a non-competitive, non-set-aside award to a critical federal medical procurement vendor. The delivery order falls under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally.
The contract is executed under an established framework where AmerisourceBergen serves as a primary pharmaceutical supplier to Defense Health Agency facilities, the U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates consistent capability in fulfilling requirements across multiple therapeutic domains, including diabetes management, neurological treatments, pain management, and specialized medical supplies. As a single-award IDC holder with the DLA, AmerisourceBergen maintains a strategic position within the Department of Defense's pharmaceutical supply chain, supporting military treatment facilities and veterans' healthcare programs with essential medical commodities on a global scale.
Quick answers
Who was awarded contract SPE2D826FCJ40?
SPE2D826FCJ40 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826FCJ40 worth?
The government has obligated $47,661 on SPE2D826FCJ40.
Is contract SPE2D826FCJ40 an order under another contract?
Yes. SPE2D826FCJ40 is a delivery order under SPE2DX22D0019, an indefinite delivery contract.
Was contract SPE2D826FCJ40 competed?
The extent of competition for SPE2D826FCJ40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award